Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Neurotrauma. 2020 Nov 15;37(22):2424-2434. doi: 10.1089/neu.2018.6220. Epub 2019 May 6.
The diagnosis and prognosis of traumatic brain injury (TBI) is complicated by variability in the type and severity of injuries and the multiple endophenotypes that describe each patient's response and recovery to the injury. It has been challenging to capture the multiple dimensions that describe an injury and its recovery to provide clinically useful information. To address this challenge, we have performed an open-ended search for panels of microRNA (miRNA) biomarkers, packaged inside of brain-derived extracellular vesicles (EVs), that can be combined algorithmically to accurately classify various states of injury. We mapped GluR2+ EV miRNA across a variety of injury types, injury intensities, history of injuries, and time elapsed after injury, and sham controls in a pre-clinical murine model ( = 116), as well as in clinical samples ( = 36). We combined next-generation sequencing with a technology recently developed by our lab, Track Etched Magnetic Nanopore (TENPO) sorting, to enrich for GluR2+ EVs and profile their miRNA. By mapping and comparing brain-derived EV miRNA between various injuries, we have identified signaling pathways in the packaged miRNA that connect these biomarkers to underlying mechanisms of TBI. Many of these pathways are shared between the pre-clinical model and the clinical samples, and present distinct signatures across different injury models and times elapsed after injury. Using this map of EV miRNA, we applied machine learning to define a panel of biomarkers to successfully classify specific states of injury, paving the way for a prognostic blood test for TBI. We generated a panel of eight miRNAs (miR-150-5p, miR-669c-5p, miR-488-3p, miR-22-5p, miR-9-5p, miR-6236, miR-219a.2-3p, miR-351-3p) for injured mice versus sham mice and four miRNAs (miR-203b-5p, miR-203a-3p, miR-206, miR-185-5p) for TBI patients versus healthy controls.
创伤性脑损伤 (TBI) 的诊断和预后因损伤类型和严重程度的可变性以及描述每个患者对损伤的反应和恢复的多种内表型而变得复杂。捕捉描述损伤及其恢复的多个维度以提供临床有用的信息一直具有挑战性。为了解决这一挑战,我们进行了开放式搜索,以寻找可以通过算法组合以准确分类各种损伤状态的脑源性细胞外囊泡 (EV) 内包装的 microRNA (miRNA) 生物标志物。我们在临床样本中( = 36)映射了 GluR2+EV miRNA,映射了各种损伤类型、损伤强度、损伤史和损伤后时间,以及假手术对照( = 116),并在临床样本中( = 36)映射了 GluR2+EV miRNA。我们将下一代测序与我们实验室最近开发的技术——Track Etched Magnetic Nanopore(TENPO)分选相结合,以富集 GluR2+EV 并对其 miRNA 进行分析。通过在各种损伤之间映射和比较脑源性 EV miRNA,我们确定了包裹在 miRNA 中的信号通路,将这些生物标志物与 TBI 的潜在机制联系起来。这些通路中的许多通路在临床前模型和临床样本之间共享,并在不同的损伤模型和损伤后时间呈现出不同的特征。利用这种 EV miRNA 图谱,我们应用机器学习来定义一组生物标志物,以成功分类特定的损伤状态,为 TBI 的预后血液检测铺平了道路。我们生成了一组 8 个 miRNA(miR-150-5p、miR-669c-5p、miR-488-3p、miR-22-5p、miR-9-5p、miR-6236、miR-219a.2-3p、miR-351-3p)用于受伤的老鼠与假手术的老鼠,以及 4 个 miRNA(miR-203b-5p、miR-203a-3p、miR-206、miR-185-5p)用于 TBI 患者与健康对照。